and u i ≤ m i, ∀ i ∈ N. Therefore, it is easy to obtain that a i i − u i R i 1 + ∑ j ≠ i u j i ≥ a i i − m i R i 1 + ∑ j ≠ i m j i, ∀ i ∈ N. Obviously, we have the desired result min i { a i i − u i R i 1 + ∑ j ≠ i u j i } ≥ min i { a i i − m i R i 1 + ∑ j ≠ i m j i }. □.
However, if it is assumed that a failure will occur before time M, obviously the probability density function will equal to 0 in the period [M, +∞].
The metazoan CSL genes (class M) obviously underwent duplication too.
More interestingly, the treatment of A172 cells with an HSP70 inhibitor, VER155008 (10 μ m), obviously induced the phosphorylation of NF-κB at both the Ser 536 and Ser 276 sites in A172 cells (Fig. 1C).
Obviously, two points M i (x i, y i ) and M j (x j, y j ) have the same projected coordinates on the (O, u ) direction if and only if M i M j is perpendicular to (O, u ).
For any (i, j) ∈ I × J,we have P(x i ) ≺ P y j ), which implies m I ≺ m J. Obviously we have [ m I, m J ] ⊂ ∩ i ∈ I [ x i, → ) ∩ ∩ i ∈ I ( ←, y j ] ∩ M ≠ ∅. Hence, M is in E C ( X ).
For example, the pretreatment physical IPV scores of completers who received I-StoP (M = 6.91) were obviously lower than ITT allocated to I-StoP (M = 12.12).
From this figure, we can see that the standard deviation increases as n increases when d=5,10 ms. However, the standard deviation when d=5 ms is obviously larger than when d=10 ms for each n.
The solutions of Problem IV on (J_{n}) ((n=1,2, ldots, M)) are obviously unique since they are obtained by projecting the solutions of (2.14) and (2.15), namely Problem III on (J_{n}) ((n=1,2, ldots, M)) into POD basis.
The changes in the T and in the M staging obviously affect tumour stages in individual cases.
In the line y=-4x+3, the slope (m) is obviously -4.
